|Articles|September 15, 2006

Express Report - New Directions and Options for the Management of Hypertension
Volume 12
Issue 1 Express

Introduction

Download PDF: Introduction

Articles in this issue

over 19 years ago

Article

New Direct Renin Inhibitor as Monotherapy or in Combination with Hydrochlorothiazide Controls Blood Pressure

over 19 years ago

Article

Valsartan Reduces Inflammatory Marker Associated with Hypertensive and Comorbid Risk; Effect Neutralized by Thiazide Diuretic

over 19 years ago

Article

The Impact of Fixed-dose Combinations on Blood Pressure Control, Persistence, and Comorbid Disease

over 19 years ago

Article

Ability to Control Blood Pressure and Choice of Antihypertensive Impact Development and Course of Comorbid Disease

over 19 years ago

Article

Initial Drug Choice and Economics Affect Healthcare Utilization and Persistence

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Introduction

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Photobiomodulation, Bio-Machines, and the Future of Dermatology

Virtual Reality Intervention Increased Empathy for Patients With MG

Tildrakizumab Shows Long-Term Psoriasis Control for Hard-to-Treat Areas

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors